search
Back to results

Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors (FoRtitude)

Primary Purpose

Breast Cancer, Fear of Cancer

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Diaphragmatic breathing and relaxation
Cognitive restructuring
Scheduled worry practice
Telephone coaching
Usual care
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer focused on measuring Fear of Cancer Recurrence, ehealth interventions, PROMIS, FoR

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Female
  • Diagnosis of breast cancer, non-metastatic, stage I-III
  • Completed primary treatment for breast cancer (surgery, chemotherapy and/or radiation therapy, current hormonal treatment allowable)
  • No current evidence of disease

    1. Greater than 1 year post treatment (for phase I interviews and usability testing)
    2. Between 1 and 10 years post-treatment (for Phase I field testing and Phase II)
  • Good overall functional status as evidenced by ECOG Performance Status < 3
  • At least 18 years of age (for Phase I only)
  • At least 19 years of age (for Phase 2 only)
  • Able to speak and read English
  • Able to provide informed consent
  • Clinically significant FoR, measured by the 9-item FCRI severity scale using established cut-off

    a. Patients may be eligible for Phase I and Phase IV of the study regardless of their FCRI score

  • Cellular telephone with SMS messaging capability and access to a computer with broadband Internet access
  • Self-reported familiarity with the Internet per Internet Usage Patterns Measure
  • For Phase III, participants must have participated in Phase II
  • For Phase IV, participants must be a self-identified African American breast cancer survivor that is willing to review site content and provide feedback in addition to meeting inclusion criteria above (with exception of FCRI severity scale score)

Exclusion Criteria:

  • Visual, hearing, voice, or motor impairment that would prevent completion of study procedures
  • Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous
  • Hazardous substance or alcohol use
  • Suicidal ideation, plan, intent
  • Dementia
  • Or if the participant is deemed ineligible by the investigators for reasons not otherwise specified.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm 4

    Arm 5

    Arm 6

    Arm 7

    Arm 8

    Arm 9

    Arm 10

    Arm 11

    Arm 12

    Arm 13

    Arm 14

    Arm 15

    Arm 16

    Arm Type

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Experimental

    Arm Label

    Group 1

    Group 2

    Group 3

    Group 4

    Group 5

    Group 6

    Group 7

    Group 8

    Group 9

    Group 10

    Group 11

    Group 12

    Group 13

    Group 14

    Group 15

    Group 16

    Arm Description

    Participants were exposed to the following conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Participants were exposed to the one of the following usual care conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.

    Participants were exposed to the following conditions: cognitive restructuring for week 1, worry practice for week 2, and General Health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: cognitive restructuring for week 1, scheduled worry practice for week 2, and General Health and Diet (General and BCSS) for week 3.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and General health and Diet (General and BCSS) for week 3.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and cognitive restructuring for week 3. Telephone coaching was given.

    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and cognitive restructuring for week 3.

    Outcomes

    Primary Outcome Measures

    Fear of Cancer Recurrence Inventory (FCRI) total score (minus Coping and Reassurance subscales)
    Questionnaire aims to better understand the experience of worries about cancer recurrence. Scaled from 1-4 with 4 being "all the time" and 1 being "never". The FCRI is the only FoR measure validated using interview to define 'caseness' and has demonstrated reliability and validity with English speaking survivors. FCRI total score to be calculated without including the Coping and Reassurance subscales defined a priori and determined by FoR theoretical model.

    Secondary Outcome Measures

    Impact of Events Scale - Revised
    Questionnaire to assess illness-related distress and post-truamatic type anxiety
    Concerns about Recurrence Scale (CARS) - 4 item severity score
    Questionnaire to assess concerns about recurrence among BCS
    PROMIS Anxiety Computer adaptive test
    Questions administered using a computer adaptive test-based algorithm to assess overall anxiety
    PROMIS Depression Computer adaptive test
    Questions administered using a computer adaptive test-based algorithm to assess depression
    PROMIS Sleep Disturbance Computer adaptive test
    Questions administered using a computer adaptive test-based algorithm to assess sleep disturbances
    PROMIS Fatigue Computer adaptive test
    Questions administered using a computer adaptive test-based algorithm to assess fatigue
    PROMIS Global Health
    Questionnaire to assess overall health and health-related quality of life
    PROMIS Applied Cognition Computer adaptive test
    Questions administered using a computer adaptive test-based algorithm to assess patient-reported cognitive impairments
    Breast Cancer Self-Efficacy scale (BCSE)
    Questionnaire to assess confidence in one's ability to manage breast cancer

    Full Information

    First Posted
    December 20, 2017
    Last Updated
    April 27, 2018
    Sponsor
    Wake Forest University Health Sciences
    Collaborators
    National Cancer Institute (NCI)
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03384992
    Brief Title
    Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors
    Acronym
    FoRtitude
    Official Title
    Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors: The FoRtitude Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2018
    Overall Recruitment Status
    Completed
    Study Start Date
    March 2014 (Actual)
    Primary Completion Date
    December 5, 2015 (Actual)
    Study Completion Date
    December 5, 2015 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Wake Forest University Health Sciences
    Collaborators
    National Cancer Institute (NCI)

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The FoRtitude trial aims to evaluate an eHealth intervention designed to teach breast cancer survivors strategies to manage anxiety about cancer recurrence. The eHealth intervention includes educational content and interactive tools, designed to teach coping strategies and/or inert content, depending on the study participant's randomization assignment. The FoRtitude study will examine whether three coping strategies (relaxation training, cognitive restructuring, worry practice) are more effective than general health-related content in reducing fear of cancer recurrence.
    Detailed Description
    The purpose of the FoRtitude trial is to develop and evaluate a targeted eHealth intervention designed to teach breast cancer survivors (BCS) coping strategies to manage fear about cancer recurrence (FoR). FoRtitude, a web-based program with interactive text messaging capabilities, was created to deliver a targeted intervention for BCS with moderate to severe FoR. FoRtitude consists of didactic content presented in written and video-based formats and interactive tools, designed to teach coping strategies. Commonly used cognitive behavior therapy (CBT) techniques were tailored to the management of FoR and included diaphragmatic breathing and relaxation, cognitive restructuring, and scheduled worry practice. Participants are encouraged to use the FoRtitude site several times per week over a period of 4 weeks. The investigators employed principles of user-centered design to create the FoRtitude website and incorporated feedback from 17 BCS to refine site content and improve FoRtitude usability. After refining the FoRtitude site, the investigators will conduct a randomized controlled trial using the Multiphase Optimization Strategy (MOST) to individually evaluate three coping strategies; each coping strategy will be compared to health management content. Inert content includes general health information and managing comorbid illnesses, information on general nutrition, and information on nutritional topics of interest to BCS. Half of the participants will be randomized to receive telecoaching, which included 3-4 telephone-based brief sessions with a motivational interviewer, aimed at improving adherence to use of the FoRtitude site. Participants will complete questionnaires at baseline, 4 weeks (immediately after completing the FoRtitude site) and at 8 weeks. Study hypotheses: BCS randomized to Relaxation training will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content BCS randomized to Cognitive restructuring will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content BCS randomized to Scheduled Worry practice will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to inert (health management) content BCS randomized to receive Telecoaching will demonstrate higher adherence to using the FoRtitude site and will report a greater reduction in fear of cancer recurrence from pre-post intervention compared to BCS randomized to no Telecoaching BCS randomized to a higher number of coping strategies will report a greater reduction in fear of cancer recurrence from pre-post intervention than BCS randomized to receive all inert content or fewer coping strategies (dose-response effect)

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Breast Cancer, Fear of Cancer
    Keywords
    Fear of Cancer Recurrence, ehealth interventions, PROMIS, FoR

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Factorial Assignment
    Model Description
    FoRtitude includes three CSMs: (1) diaphragmatic breathing and relaxation, (2) cognitive restructuring, and (3) scheduled worry practice. The fourth intervention component is (4) telephone coaching. We assigned two levels (yes, no) to each component. Evaluating individual and combined intervention components, each with two levels, results in a classic full factorial design with 16 (2 x 2 x 2 x 2) experimental conditions
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    215 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Group 1
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.
    Arm Title
    Group 2
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the one of the following usual care conditions: general health for week 1, diet-general information for week 2, and diet-BCSS information (breast cancer survivor-specific) for week 3.
    Arm Title
    Group 3
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.
    Arm Title
    Group 4
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: cognitive restructuring for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.
    Arm Title
    Group 5
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3. Telephone coaching was given.
    Arm Title
    Group 6
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: scheduled worry practice for week 1, general health for week 2, and diet-general information and diet-BCSS information (breast cancer survivor-specific) for week 3.
    Arm Title
    Group 7
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: cognitive restructuring for week 1, worry practice for week 2, and General Health and Diet (General and BCSS) for week 3. Telephone coaching was given.
    Arm Title
    Group 8
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: cognitive restructuring for week 1, scheduled worry practice for week 2, and General Health and Diet (General and BCSS) for week 3.
    Arm Title
    Group 9
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3. Telephone coaching was given.
    Arm Title
    Group 10
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, general health for week 2, and Diet - General and BCSS for week 3.
    Arm Title
    Group 11
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.
    Arm Title
    Group 12
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, cognitive restructuring for week 2, and General health and Diet (General and BCSS) for week 3.
    Arm Title
    Group 13
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and General health and Diet (General and BCSS) for week 3. Telephone coaching was given.
    Arm Title
    Group 14
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and General health and Diet (General and BCSS) for week 3.
    Arm Title
    Group 15
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, worry practice for week 2, and cognitive restructuring for week 3. Telephone coaching was given.
    Arm Title
    Group 16
    Arm Type
    Experimental
    Arm Description
    Participants were exposed to the following conditions: Diaphragmatic breathing and relaxation for week 1, scheduled worry practice for week 2, and cognitive restructuring for week 3.
    Intervention Type
    Other
    Intervention Name(s)
    Diaphragmatic breathing and relaxation
    Intervention Description
    Education on physiological effects of anxiety, instructions in diaphragmatic breathing and relaxation techniques, and audio-recordings 5-15 minutes in length that provide guided relaxation exercises (autogenic, imagery-based and progressive muscle relaxation).
    Intervention Type
    Other
    Intervention Name(s)
    Cognitive restructuring
    Intervention Description
    Education on the thought-emotion connection and exercises designed to better understand cognitions associated with increased anxiety and tools to evaluate and replace anxiety-generating cognitions. Includes an interactive tool (thought record) participants complete to facilitate this process.
    Intervention Type
    Other
    Intervention Name(s)
    Scheduled worry practice
    Intervention Description
    Education on the association between avoidance and increased anxiety, and instructions on actively thinking about feared events to reduce avoidance and engage healthy coping strategies. Interactive tool includes a video-based guided worry practice session and an interactive worksheet and timer.
    Intervention Type
    Other
    Intervention Name(s)
    Telephone coaching
    Intervention Description
    BCS will receive 5 TeleCoaching calls over a period of 4 weeks, to include one introductory phone call, followed by 4 calls focused each week on the current CSM; if the participant is not randomized to a CSM, TeleCoaching will provide reflective listening and encouragement.
    Intervention Type
    Other
    Intervention Name(s)
    Usual care
    Intervention Description
    Includes general health, diet-general information and diet-BCSS (breast cancer survivor-specific) information.
    Primary Outcome Measure Information:
    Title
    Fear of Cancer Recurrence Inventory (FCRI) total score (minus Coping and Reassurance subscales)
    Description
    Questionnaire aims to better understand the experience of worries about cancer recurrence. Scaled from 1-4 with 4 being "all the time" and 1 being "never". The FCRI is the only FoR measure validated using interview to define 'caseness' and has demonstrated reliability and validity with English speaking survivors. FCRI total score to be calculated without including the Coping and Reassurance subscales defined a priori and determined by FoR theoretical model.
    Time Frame
    Baseline to Week 8 change score
    Secondary Outcome Measure Information:
    Title
    Impact of Events Scale - Revised
    Description
    Questionnaire to assess illness-related distress and post-truamatic type anxiety
    Time Frame
    Baseline to Week 8 change score
    Title
    Concerns about Recurrence Scale (CARS) - 4 item severity score
    Description
    Questionnaire to assess concerns about recurrence among BCS
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Anxiety Computer adaptive test
    Description
    Questions administered using a computer adaptive test-based algorithm to assess overall anxiety
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Depression Computer adaptive test
    Description
    Questions administered using a computer adaptive test-based algorithm to assess depression
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Sleep Disturbance Computer adaptive test
    Description
    Questions administered using a computer adaptive test-based algorithm to assess sleep disturbances
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Fatigue Computer adaptive test
    Description
    Questions administered using a computer adaptive test-based algorithm to assess fatigue
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Global Health
    Description
    Questionnaire to assess overall health and health-related quality of life
    Time Frame
    Baseline to Week 8 change score
    Title
    PROMIS Applied Cognition Computer adaptive test
    Description
    Questions administered using a computer adaptive test-based algorithm to assess patient-reported cognitive impairments
    Time Frame
    Baseline to Week 8 change score
    Title
    Breast Cancer Self-Efficacy scale (BCSE)
    Description
    Questionnaire to assess confidence in one's ability to manage breast cancer
    Time Frame
    Baseline to Week 8 change score

    10. Eligibility

    Sex
    Female
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Female Diagnosis of breast cancer, non-metastatic, stage I-III Completed primary treatment for breast cancer (surgery, chemotherapy and/or radiation therapy, current hormonal treatment allowable) No current evidence of disease Greater than 1 year post treatment (for phase I interviews and usability testing) Between 1 and 10 years post-treatment (for Phase I field testing and Phase II) Good overall functional status as evidenced by ECOG Performance Status < 3 At least 18 years of age (for Phase I only) At least 19 years of age (for Phase 2 only) Able to speak and read English Able to provide informed consent Clinically significant FoR, measured by the 9-item FCRI severity scale using established cut-off a. Patients may be eligible for Phase I and Phase IV of the study regardless of their FCRI score Cellular telephone with SMS messaging capability and access to a computer with broadband Internet access Self-reported familiarity with the Internet per Internet Usage Patterns Measure For Phase III, participants must have participated in Phase II For Phase IV, participants must be a self-identified African American breast cancer survivor that is willing to review site content and provide feedback in addition to meeting inclusion criteria above (with exception of FCRI severity scale score) Exclusion Criteria: Visual, hearing, voice, or motor impairment that would prevent completion of study procedures Diagnosed with a psychotic disorder, bipolar disorder, dissociative disorder, or other diagnosis for which participation in this trial is either inappropriate or dangerous Hazardous substance or alcohol use Suicidal ideation, plan, intent Dementia Or if the participant is deemed ineligible by the investigators for reasons not otherwise specified.
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Lynne Wagner, Ph.D.
    Organizational Affiliation
    Wake Forest University Health Sciences
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors

    We'll reach out to this number within 24 hrs